IRD
Opus Genetics, Inc.
5.00$
-1.9%
vs. previous close
Closing price · As of: Sep 29, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 0.0% | 277.8% | – | – | – | 180.8% | 0.3% | 209.0% | 0.4% | 0.3% | 0.6% | – | – | |
| 100.0% | -177.8% | 100.0% | 100.0% | 100.0% | -80.8% | 100.0% | -109.0% | 100.0% | 100.0% | 99.4% | 100.0% | 99.9% | |
| 29.3% | 227.1% | 277.6% | 547.3% | 232.3% | 163.5% | 182.0% | 209.0% | 208.2% | 269.8% | 490.4% | 1,484.4% | 391.9% | |
| 17.2% | 193.9% | 272.9% | 301.6% | 74.8% | 169.6% | 145.2% | 200.1% | 161.8% | 126.5% | 275.0% | 798.4% | 221.5% | |
| 46.5% | 143.2% | 550.5% | 848.9% | 307.1% | 803.2% | 327.2% | 200.1% | 369.9% | 396.3% | 765.3% | 2,282.8% | 613.3% | |
| 53.5% | -321.1% | -450.5% | -748.9% | -207.1% | -884.0% | -227.2% | -309.0% | -269.9% | -296.3% | -665.9% | -2,182.8% | -513.5% | |
| 11.1% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 31.4% | 1.2% | 2.2% | 36.2% | 30.2% | 70.3% | 26.9% | |
| 46.7% | -283.7% | -415.3% | -698.3% | -194.6% | -816.7% | -187.5% | -257.5% | -566.9% | -427.5% | -3,038.2% | -1,072.6% | -1,091.8% | |
| 0.1% | -0.1% | – | – | – | – | – | – | – | – | – | – | – | |
| 46.6% | -283.6% | -415.3% | -698.3% | -194.6% | -816.7% | -187.5% | -257.5% | -566.9% | -427.5% | -3,038.2% | -1,072.6% | -1,091.8% | |
| 57.8% | -283.5% | -415.3% | -698.3% | -194.6% | -233.1% | -155.8% | -255.8% | -564.2% | -391.0% | -3,007.5% | -1,002.3% | -1,064.6% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.